Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H18O2 |
| Molecular Weight | 170.2487 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC[C@H](C[C@@H]1O)C(C)(C)O
InChI
InChIKey=OMDMTHRBGUBUCO-BDAKNGLRSA-N
InChI=1S/C10H18O2/c1-7-4-5-8(6-9(7)11)10(2,3)12/h4,8-9,11-12H,5-6H2,1-3H3/t8-,9+/m1/s1
| Molecular Formula | C10H18O2 |
| Molecular Weight | 170.2487 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
trans-Sobrerol is a mucolytic known due its emplyment in therapy for respiratory diseases. In preclinical studies sobrerol, administered daily at the oral dose of 400 mg/rat, markedly decreased the monocrotaline-induced alterations and regulate the development of pulmonary hypertension. Treatment with sobrerol was well tolerated and significantly reduced frontal headache and rhinorrhoea, efficacy being confirmed by rhinomanometry.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:07 GMT 2025
by
admin
on
Mon Mar 31 18:09:07 GMT 2025
|
| Record UNII |
AI0NX02O35
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QR05CB07
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
||
|
WHO-ATC |
R05CB07
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
42370-41-2
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
207-868-1
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
ALTERNATIVE | |||
|
SUB15264MIG
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL459048
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
DB13315
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
36669
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000091778
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
AI0NX02O35
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
m9975
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
498-71-5
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
255-780-7
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
2454
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
DTXSID501317156
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY | |||
|
SOBREROL
Created by
admin on Mon Mar 31 18:09:07 GMT 2025 , Edited by admin on Mon Mar 31 18:09:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE |
|
||
|
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |